Literature DB >> 5543916

Glucagon: a new agent in cardiac therapy.

W W Parmley, E H Sonnenblick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5543916     DOI: 10.1016/0002-9149(71)90307-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

Review 1.  Altered hepatic blood flow and drug disposition.

Authors:  A S Nies; D G Shand; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Effects of glucagon and secretin on food- or morphine-induced motor activity of the distal colon, rectum, and anal sphincter.

Authors:  A R Chowdhury; S H Lorber
Journal:  Am J Dig Dis       Date:  1977-09

3.  [Biochemical and haemodynamic effects of zinc-protamin-glucagon in man (author's transl)].

Authors:  P Kühn; P Holzhey; M Niederberger; H Fritzsche; A Kroiss; B Brenner; F Kaindl
Journal:  Klin Wochenschr       Date:  1973-10-01

4.  Haemodynamic effects of isoprenaline in acute myocardial infarction.

Authors:  J Beregovich; H Reicher-Reiss; A Grishman
Journal:  Br Heart J       Date:  1972-07

5.  Effect of glucagon on infants and children with atrioventricular heart block.

Authors:  R A Hurwitz
Journal:  Br Heart J       Date:  1973-12

6.  Protective effects of glucagon during the anaphylactic response in guinea-pig isolated heart.

Authors:  I Andjelkovic; B Zlokovic
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

Review 7.  Glucagon and heart in type 2 diabetes: new perspectives.

Authors:  Antonio Ceriello; Stefano Genovese; Edoardo Mannucci; Edoardo Gronda
Journal:  Cardiovasc Diabetol       Date:  2016-08-27       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.